Investors

Press Releases

Dec 13, 2022 • 9:11 AM EST

Endonovo Launches Telehealth Initiative

Nov 30, 2022 • 9:07 AM EST

Endonovo Names Ira Weisberg President to Guide Global Medical Expansion

Nov 17, 2022 • 9:07 AM EST

ENDONOVO ANNOUNCES PLAN TO EXPLORE STRATEGIC ALTERNATIVES FOR ITS SOFPULSE® MEDICAL DEVICE ASSETS

Nov 7, 2022 • 9:07 AM EST

Endonovo Therapeutics Issues Corporate Update

Sep 27, 2022 • 1:52 PM EDT

Endonovo Therapeutics Signs Definitive Asset Purchase Agreement to Acquire A Highly Profitable Texas Concrete Construction Company

Jul 28, 2022 • 9:08 AM EDT

Endonovo Therapeutics Releases Comparative Analysis Demonstrating

Jul 21, 2022 • 11:30 AM EDT

Endonovo Therapeutics Releases A Comparative Analysis Addressing Limitations Of Non-Opioid Pharmaceutical Interventions on the Reduction of Opioid/Narcotic Use For Post-Surgical Pain Management

Jun 9, 2022 • 2:02 PM EDT

Endonovo Therapeutics Announces LOI to Acquire Specialty Construction Company

Apr 25, 2022 • 9:08 AM EDT

Endonovo Therapeutics Signs Agreement with NAMSA to Develop Reimbursement Strategy for Endonovo Medical Products

Apr 11, 2022 • 9:08 AM EDT

$5 Million Common Stock Offering for Endonovo Therapeutics Designed to Advance SofPulse® Process for Medical Reimbursement

<< Previous
1
2
3
4
5
6
7
8
9
10
...16
Next >>

Show All